Thor Medical ASA (OSTO:NANOO) Additional Paid-In Capital : kr246.07 Mil(As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Additional Paid-In Capital?

Thor Medical ASA's quarterly additional paid-in capital increased from Dec. 2022 (kr66.55 Mil) to Jun. 2023 (kr67.40 Mil) and increased from Jun. 2023 (kr67.40 Mil) to Dec. 2023 (kr246.07 Mil).

Thor Medical ASA's annual additional paid-in capital declined from Dec. 2021 (kr179.73 Mil) to Dec. 2022 (kr66.55 Mil) but then increased from Dec. 2022 (kr66.55 Mil) to Dec. 2023 (kr246.07 Mil).

Thor Medical ASA Additional Paid-In Capital Historical Data

The historical data trend for Thor Medical ASA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Additional Paid-In Capital Chart

Thor Medical ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

404.36

179.94

179.73

66.55

246.07

Thor Medical ASA Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															311.97	214.28	66.55	67.40	246.07

Thor Medical ASA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Thor Medical ASA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA (OSTO:NANOO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 0R6Y:UK 8NN:Germany

Address

Kjelsasveien 168 B, Oslo, NOR, 0884

Website

https://www.nordicnanovector.com

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (OSTO:NANOO) Headlines

No Headlines